Gene therapy

Trends in investment for cell and gene therapies

Read more

AAV-based gene therapies poised for uplift

Read more

Caszyme pioneers gene editing from Lithuania

Read more

Changes in the landscape for genome editing

Read more

Genome editing for inherited ocular diseases

Read more

The outlook for gene editing in treating disease

Read more

WHO panel advises on governance of genome editing

Read more

VectorY Therapeutics targets misfolded proteins

Read more

A new paradigm for gene therapy

Read more

Addressing the challenges of gene therapy medicinal products

Read more